Verge Genomics to Incorporate Emerald Digital Health Technology into its ALS Phase 1b…
Emerald AI platform and “invisible” sensors to capture critical patient data and measure changes in clinical function in patients treated with…
Browsing Tag
biotechnology
GeoVax Announces Expansion of Next-Generation COVID-19 Vaccine Rights to Include Omicron Variants…
GeoVax Labs, a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced the expansion of its…
Immunis Appoints Neil Sahota as Chief Artificial Intelligence Officer
Immunis, a private biotechnology company developing a novel treatment for age and disease-related immune decline, has appointed Neil Sahota as its…
Evaxion And Pennsylvania State University Publish Preclinical Data Validating Our AI-based Viral…
Evaxion Biotech A/S, a clinical-stage biotechnology company specializing in AI-powered immunotherapies, announces the successful publication in…
Genomic Vision Joins France BioLead to Advance Innovation and Production of Biopharmaceuticals in…
Participation in France BioLead reflects the Company's growing focus on innovation for bioproduction in line with its strategy to accelerate…
Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine…
Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library…
Seismic Therapeutic Appoints Melanie Manning as Chief People Officer
Seismic Therapeutic, a biotechnology company using machine learning for immunology drug development, announced that Melanie Manning has joined the…
REVEAL GENOMICS´ Breakthrough Technology Enters the Liquid Biopsy Field in Oncology
REVEAL GENOMICS, S.L., a Barcelona-based biotechnology start-up seeking to revolutionize precision oncology through biomarker innovation, announced a…
Genomic Vision Launches Fibersmart, AI-powered Software For Automating Genomic Analysis
Seamless user experience offering up to three times more precision and ten times faster analysis than our previous software
The platform…
Thymmune Secures $7 Million in Seed Financing to Develop Thymus Cell Therapy Platform for Immune…
Thymmune Therapeutics, a biotechnology company developing scalable thymic cell therapies to restore immune function in aging and disease, announced …